Document is current
Any future updates will be listed below
-
Authors
Akbarinejad, Shaya
Doppler, Sarah
Graaf, Jos de
Pistolic-Kraft, Jelena
Bukur, Valesca
Albrecht, Christian
Buchholz, Nathalie
Özenoglu, Simge
Sahin, Ugur
Ibn-Salem, Jonas
Weber, David
-
Funding
Funding for this research was provided by:
TRON – Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gemeinnützige GmbH
- License Information
-
More Information
Article History
Received: 13 October 2025
Accepted: 4 June 2026
First Online: 23 June 2026
Declarations
:
: The research project was conducted in accordance with the principles of the Declaration of Helsinki.
: All human samples were commercially purchased and collected under informed written consent with explicit permission for DNA testing and publication.
: Ugur Sahin is a co-founder, Chief Executive Officer, and shareholder of BioNTech SE. Christian Albrecht und Sarah Doppler are employees of BioNTech SE.
